INTRODUCTION
============

An inheritable disorder of autosomal dominance, Dupuytren's disease (DD) is a common fibroproliferative disorder causing flexion contractures of the hand. It is known to affect individuals between the fifth and seventh decades, with a geographical distribution that broadly follows the migration patterns of Northern Europeans around the globe.^[@R1]^ Most commonly DD involves contracture of the small finger, with a single digit involved in 60% of the patients.^[@R2]^ The tissue in DD is composed of cords, consisting of scanty fibroblasts, and nodules, consisting of whorls of cells. The contractile ability of the disease is the result of myofibroblasts' cells that are otherwise typically seen in normal wound healing. In DD, the formation of nodules and cords progresses from an initial cellular proliferative stage, through an intermediate fibrocellular stage, to a terminal fibrotic stage.^[@R3]^

A contracture that interferes with function is the most common indication for surgical intervention. Various surgical treatment modalities exist, such as fasciotomy, fasciectomy, and dermofasciectomy. However, recurrence rates remain high following surgical treatment, which ranges from 12% to 39%. In 1979, Rudolph^[@R4]^ demonstrated that myofibroblasts are inhibited by the presence of full-thickness skin grafts, and in 1993, McCann et al observed that in a large proportion of samples from patients with DD, myofibroblasts were found to be extending into the dermis.^[@R5],[@R6]^ These findings may demonstrate why procedures that leave the overlying dermis intact have a high recurrence rate, possibly due to the abnormal interaction between the overlying dermis and underlying connective tissue layers in the development of DD. Previous studies demonstrate recurrence rates as low as 12.2% with use of a full-thickness skin graft and \<5% with use of acellular dermal matrix (ADM) as reported by a single study.^[@R7]^ In this study, we aimed to further evaluate the use of ADM to reduce recurrence rates based on the postulate that ADM has an inhibitory effect on underlying myofibroblasts.

METHODS
=======

We performed a retrospective cohort study of 132 patients undergoing open fasciectomy for DD from years 2007 to 2017 performed by a single surgeon (DK) at our academic institution. Only patients with symptomatic DD with the presence of nodules and/or joint contracture were included in this study.

Standard McCash technique fasciectomies of affected palmar and digital fascia were performed. Patients in the experimental group had a sheet of ADM (FlexHD; Musculoskeletal Transplant Foundation, Edison, NJ) sutured into the surgical bed with absorbable sutures (Fig. [1](#F1){ref-type="fig"}), whereas patients in the control group were not closed with ADM. ADM was utilized in place of a full-thickness skin graft. The thickness of the ADM was not measured in each patient, but product specifications were followed from manufacturer (Table [1](#T1){ref-type="table"}). Patients in the control group were not closed with acellular dermal matrix but instead were allowed to heal by secondary intention. Patients were then evaluated at follow-up for disease recurrence, defined as the presence of Dupuytren tissue in an area previously operated on with a contracture greater than that recorded following the surgical fasciectomy, or presence of contracture requiring surgery.

###### 

Structure and Dimension of ADM
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![Intraoperative view of (A) fasciectomy and ADM inset into (B) fasciectomy wound.](gox-7-e2263-g002){#F1}

Statistical Analyses
--------------------

Bivariate analysis was performed using the chi-square test. Wilcoxon signed rank test and Mann--Whitney test were used to determine statistical differences between the paired pre- and postoperative measurements. *P* values were two-tailed, and values ≤0.05 were defined as statistically significant.

RESULTS
=======

Results are detailed in Table [2](#T2){ref-type="table"}. Among the cohort of 132 patients, 28 (21.2%) patients were treated with acellular dermal matrix (Figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}), whereas 104 (78.8%) patients were not. The median age was 67.0 years (range 34--91 and 39--82 years in the control and dermal matrix groups, respectively). No statistical difference existed between each group regarding age, comorbidities, and laterality. The most common comorbidity was a smoking history, with 34% in the control group versus 43% in the dermal matrix group. There was no significant difference between each group regarding the type of previous treatments, such as collagenase and surgery. Distribution of the affected area was similar except for increased involvement of the small finger in the ADM group (*P* = 0.002).

###### 

Characteristics of Control and Acellular Dermal Matrix Patient Cohorts
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![Closure with ADM of palm and fifth digit. (A) Preoperative and (B) postoperative views of palm and fifth digit closed with ADM.](gox-7-e2263-g004){#F2}

![Postoperative view of patient showing improved range of motion (ROM).](gox-7-e2263-g005){#F3}

The mean preoperative interphalangeal joint flexion contracture in the ADM group of 66.5 ± 29.9 degrees was corrected to 9.7 ± 12.4 degrees, whereas the mean metacarpophalangeal joint preoperative flexion contracture of 51.4 ± 23.9 degrees was corrected to 7.8 ± 14.1 degrees at postoperative examination (*P* \< 0.05). The median follow-up was 18.7 months, during which the recurrence of contracture was observed in 1 of 28 patients in the group receiving ADM, compared with 9 of 104 in the control group (*P* = 0.37). Of all patients, 2 complications occurred in the control group---infection and complex regional pain syndrome. There were no differences in the incidence of complications observed.

DISCUSSION
==========

Ongoing debate exists regarding the optimal surgical method in treating DD---whether to utilize traditional open fasciectomy, limited procedures, or less invasive techniques, as well as when to use alternative operative techniques such as wide-awake open release and 2-stage treatments.^[@R8]^ Reported recurrence rates for open fasciectomy in treating DD varies widely within current literature. Multiple large studies with long-term follow-up suggest that these traditional procedures are associated with high recurrence rates, from 39% following fasciectomy to 62% following fasciotomy.^[@R9]^ Hueston^[@R10],[@R11]^ reported in 1962 and 1969 the observation of no recurrences in patients who underwent full-thickness excision of skin and diseased fascia and full-thickness skin grafting, later termed dermofasciectomy. Since then, additional studies demonstrate the lower recurrence rates for dermofasciectomy,^[@R12]--[@R20]^ further suggesting the association of the dermis overlying the diseased fascia with disease recurrence. Therefore, it has been hypothesized that a barrier between the wound bed and the overlying dermis could replicate the success rate of dermofasciectomy by blocking the interaction between wound and dermis and thus avoid the disadvantages in excising the skin completely and using full-thickness skin grafts.^[@R6]^

Human ADM was released in 1994 for the replacement of inadequate integumental tissue due to burn injury and has since been found useful as skin replacement for its ability to retain elastin and collagen fibers after undergoing decellularization and sterilization.^[@R21]^ In a review on the use of ADM in forearm, wrist, and hand reconstruction, Ellis and Kulber^[@R22]^ found that ADM offers innovative utility in solving upper extremity surgical problems, but that more comparative trials are necessary. Nevertheless, little is known about the use of ADM in surgically treating DD and has only previously been studied in small cohorts and implicated as a successful viable alternative to the standard procedure.^[@R6]^ In this study, we observed similar results to that of Terry et al.^[@R6]^ Although not statistically significant, there was a trend toward lower recurrence rates in the ADM group. The patient history, such as experience with age, laterality, previous surgery, and comorbidities, was similar regardless of treatment group. Interestingly, flexion of the MPJ was significantly better both preoperatively and postoperatively in the dermal matrix group and complication rates were comparable and low to none for both groups. This indicates that ADM is a viable surgical option, but further studies are required, with a larger sample size, to elucidate this option.

As such, our study is not without limitations, with an unequal distribution of patients between the experimental and control groups. Furthermore, the experimental ADM group had shorter follow-up and fewer patients than the control group. However, we hope that these results can lead to a prospective double-blinded study that can further elucidate surgical treatment utilizing ADM for DD. An ideal future study can involve a prospective study of greater power with similar duration, longer follow-up, and an additional control group with skin grafting.

Overall, we found that the adjunct placement of acellular dermal matrix into the wound bed following fasciectomy for DD may be an important surgical strategy to reduce recurrence rates as well as augment coverage of exposed vital structures in cases of severe flexion contracture.
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